Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IBBNYSEARCA:VHTNYSEARCA:XBINYSEARCA:XLV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBBiShares Biotechnology ETF$118.29+0.4%$130.13$107.43▼$150.57$5.29B0.841.36 million shs1.17 million shsVHTVanguard Health Care ETF$246.13-0.4%$262.30$234.11▼$289.14$21.48B0.74211,186 shs259,738 shsXBISPDR S&P Biotech ETF$75.93+1.1%$84.02$66.66▼$105.47$4.79B18.99 million shs10.41 million shsXLVHealth Care Select Sector SPDR Fund$135.49-0.6%$143.93$129.66▼$159.64$35.78B0.717.79 million shs9.66 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBBiShares Biotechnology ETF+0.42%+4.55%-11.78%-10.83%-6.04%VHTVanguard Health Care ETF-0.42%+0.74%-7.86%-4.80%-2.74%XBISPDR S&P Biotech ETF+1.06%+6.03%-11.88%-13.69%-10.30%XLVHealth Care Select Sector SPDR Fund-0.59%+0.44%-7.73%-3.35%-2.12%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/AVHTVanguard Health Care ETFN/AN/AN/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/AN/AN/AN/AN/AN/AN/AXLVHealth Care Select Sector SPDR FundN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIBBiShares Biotechnology ETF 2.68Moderate Buy$118.29N/AVHTVanguard Health Care ETF 2.78Moderate Buy$246.13N/AXBISPDR S&P Biotech ETF 2.76Moderate Buy$75.93N/AXLVHealth Care Select Sector SPDR Fund 2.77Moderate Buy$135.49N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AVHTVanguard Health Care ETFN/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/AN/AN/AN/AN/AXLVHealth Care Select Sector SPDR FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIBBiShares Biotechnology ETFN/AN/A24.21∞N/AN/AN/AN/AN/AVHTVanguard Health Care ETFN/AN/A28.31∞N/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/A11.47∞N/AN/AN/AN/AN/AXLVHealth Care Select Sector SPDR FundN/AN/A29.15∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIBBiShares Biotechnology ETF$0.380.32%N/AN/AN/AVHTVanguard Health Care ETF$3.991.62%N/AN/AN/AXBISPDR S&P Biotech ETF$0.140.18%N/AN/AN/AXLVHealth Care Select Sector SPDR Fund$2.341.73%N/AN/AN/ALatest XLV, VHT, IBB, and XBI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/17/2025IBBiShares Biotechnology ETF$0.12123/18/20253/18/20253/21/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIBBiShares Biotechnology ETF62.45%VHTVanguard Health Care ETFN/AXBISPDR S&P Biotech ETFN/AXLVHealth Care Select Sector SPDR FundN/AInsider OwnershipCompanyInsider OwnershipIBBiShares Biotechnology ETFN/AVHTVanguard Health Care ETFN/AXBISPDR S&P Biotech ETFN/AXLVHealth Care Select Sector SPDR FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIBBiShares Biotechnology ETFN/A44.70 millionN/AOptionableVHTVanguard Health Care ETFN/A87.27 millionN/ANot OptionableXBISPDR S&P Biotech ETFN/A63.08 millionN/ANot OptionableXLVHealth Care Select Sector SPDR FundN/A264.07 millionN/ANot OptionableXLV, VHT, IBB, and XBI HeadlinesRecent News About These CompaniesHealth Care Select Sector SPDR Fund (NYSEARCA:XLV) Stock Crosses Below Two Hundred Day Moving Average - Here's What HappenedApril 12, 2025 | americanbankingnews.com5 Sector ETFs Set for Q1 Earnings Growth Amid Tariff WoesApril 11, 2025 | zacks.comShould You Invest in the Health Care Select Sector SPDR ETF (XLV)?April 10, 2025 | zacks.comShould You Invest in the Health Care Select Sector SPDR ETF (XLV)?April 10, 2025 | zacks.comHealthcare Stocks Aren’t a Shelter From the Tariff StormApril 9, 2025 | msn.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comHealthcare Stocks Aren't a Shelter From the Tariff StormApril 9, 2025 | barrons.comHealthcare Stocks Aren't a Shelter From the Tariff StormApril 9, 2025 | barrons.com5 ETF Picks for AprilApril 8, 2025 | zacks.com5 ETF Picks for AprilApril 8, 2025 | zacks.comXLV: My Method For Navigating These PullbacksApril 4, 2025 | seekingalpha.comConsumer staples Q1 roundup: Philip Morris tops chart, Target worse performerApril 2, 2025 | msn.comSolventum Stock: Is SOLV Outperforming the Healthcare Sector?April 2, 2025 | msn.comBe Smart This April Fool's Day: Buy Market-Beating ETFs of Q1April 1, 2025 | zacks.comWaters Corporation Stock: Is WAT Outperforming the Healthcare Sector?March 26, 2025 | msn.comS&P sector rankings as the first quarter of 2025's close is around the cornerMarch 24, 2025 | msn.com3 Sector ETFs & Stocks to Gain Despite Downbeat February Jobs DataMarch 14, 2025 | zacks.comMerck and 8 More Healthcare Stocks for Nervous Dividend InvestorsMarch 13, 2025 | msn.comSelect Sector SPDR ETFs: Strategic Investment with Sector-Specific AllocationsMarch 12, 2025 | finance.yahoo.comS&P 500 Earnings Set to Shine: January's Critical Market Test (XLV)December 27, 2024 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?Are Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?3 Defense Stocks Set to Benefit From Increased Military SpendingBy Chris Markoch | March 20, 2025View 3 Defense Stocks Set to Benefit From Increased Military Spending5 Highest-Rated Dividend Stocks According to MarketBeatBy Thomas Hughes | April 10, 2025View 5 Highest-Rated Dividend Stocks According to MarketBeat3 Stocks With Explosive Sales Growth and Strong Cash FlowBy Leo Miller | April 14, 2025View 3 Stocks With Explosive Sales Growth and Strong Cash FlowXLV, VHT, IBB, and XBI Company DescriptionsiShares Biotechnology ETF NASDAQ:IBB$118.29 +0.50 (+0.42%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$118.28 -0.01 (0.00%) As of 04/17/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Vanguard Health Care ETF NYSEARCA:VHT$246.13 -1.03 (-0.42%) Closing price 04/17/2025 04:10 PM EasternExtended Trading$246.70 +0.56 (+0.23%) As of 04/17/2025 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vanguard Health Care ETF seeks to track the investment performance of the MSCI US Investable Market Health Care 25/50 Index, a benchmark of large-, mid-, and small-cap United States stocks in the health care sector, as classified under the Global Industry Classification Standard (GICS). This GICS sector is made up of two main industry groups. The first group includes companies that manufacture health care equipment and supplies or provide health care related services (such as distributors of health care products, providers of basic health care services, and owners and operators of health care facilities and organizations). The second group includes companies primarily involved in the research, development, production, and marketing of pharmaceuticals and biotechnology products. The Vanguard Group, Inc., through its Quantitative Equity Group, serves as the investment advisor of the Fund.SPDR S&P Biotech ETF NYSEARCA:XBI$75.93 +0.80 (+1.06%) Closing price 04/17/2025 04:10 PM EasternExtended Trading$75.77 -0.16 (-0.21%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.Health Care Select Sector SPDR Fund NYSEARCA:XLV$135.49 -0.80 (-0.59%) Closing price 04/17/2025 04:10 PM EasternExtended Trading$135.50 +0.00 (+0.00%) As of 04/17/2025 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Archer Aviation Unveils NYC Network Ahead of Key Earnings Report Joby Aviation Stock Presents an Opportunity in the Turbulence Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally Tariff-Resistant Kinder Morgan Is a Good Buy in 2025 Rocket Lab's Growth Potential Gains Altitude on Defense News Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks Tariff-Resistant Abbott Laboratories on Track for New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
